Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Zhejiang Haibo Biotech Co. Ltd. manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action associated with this company. This single action represents the current active engagement with the patent office for their biotechnological research.
The prosecution is concentrated, involving 1 distinct examiner and 1 distinct art unit. This suggests that the company's intellectual property is focused on a technical niche that does not cross into multiple regulatory jurisdictions. The use of 1 art unit provides a consistent environment for the examination process.
SCHLIENTZ, LEAH H is the busiest examiner, currently managing 1 busiest examiner pending office action. This examiner is responsible for the only active matter in the portfolio. The company's immediate prosecution results are therefore dependent on the specific review and feedback provided by this individual.
Managing 1 pending office action allows for concentrated legal resources on a single matter. The direct relationship with SCHLIENTZ, LEAH H simplifies the communication strategy for the applicant. This streamlined approach avoids the variability often found when dealing with multiple distinct examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLIENTZ, LEAH H | 1 | 41.9% | +38.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023526 | TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING | SCHLIENTZ, LEAH H | 14d |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18023526 | TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | 14d | Pending | Feb 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial